(Q42268606)

19 October 2017

title

Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study (English)

1 reference

19 October 2017

L Rostaing

1

1 reference

19 October 2017

F Vincenti

2

1 reference

19 October 2017

J Grinyó

3

1 reference

19 October 2017

K M Rice

4

1 reference

19 October 2017

B Bresnahan

5

1 reference

19 October 2017

S Steinberg

6

1 reference

19 October 2017

S Gang

7

1 reference

19 October 2017

L E Gaite

8

1 reference

19 October 2017

M-C Moal

9

1 reference

19 October 2017

G A Mondragón-Ramirez

10

1 reference

19 October 2017

J Kothari

11

1 reference

19 October 2017

L Pupim

12

1 reference

19 October 2017

C P Larsen

13

1 reference

19 October 2017

language of work or name

English

0 references

publication date

18 September 2013

1 reference

American Journal of Transplantation

19 October 2017

published in

1 reference

19 October 2017

volume

13

1 reference

19 October 2017

issue

11

1 reference

19 October 2017

page(s)

2875-2883

1 reference

Long-term renal allograft survival in the United States: a critical reappraisal

19 October 2017

cites work

1 reference

Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles

21 January 2018

1 reference

A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

21 January 2018

1 reference

Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.

21 January 2018

1 reference

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss.

21 January 2018

1 reference

MDRD-estimated GFR at one year post-renal transplant is a predictor of long-term graft function

21 January 2018

1 reference

Use of 12-month renal function and baseline clinical factors to predict long-term graft survival: application to BENEFIT and BENEFIT-EXT trials.

21 January 2018

1 reference

The implications of acute rejection and reduced allograft function on health care expenditures in contemporary US kidney transplantation.

21 January 2018

1 reference

Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trial

21 January 2018

1 reference

Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation1,2

21 January 2018

1 reference

Adherence, patient preference and dosing frequency: understanding the relationship

21 January 2018

1 reference

Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/AJT.12460

1 reference

19 October 2017

1 reference